Understand the source comparison
Peptides for Ulcer Healing: Form Comparison
BPC-157 (acetate salt) VEGF-A activation, angiogenesis enhancement 10 mcg/kg to 10 mg/kg (animal models) 50–60% ulcer size reduction at 14 days Strongest evidence base for gastric tissue repair; acetate form most studied Thymosin Beta-4 Actin sequestration, ce
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157 (acetate salt)
- VEGF-A activation, angiogenesis enhancement
- 10 mcg/kg to 10 mg/kg (animal models)
- 50–60% ulcer size reduction at 14 days
- Strongest evidence base for gastric tissue repair; acetate form most studied
- Thymosin Beta-4
- Actin sequestration, cell migration support
- 6 mg/kg (intraperitoneal, animal models)
- 35% ulcer area reduction at 14 days
- Proven in wound healing broadly; gastric-specific data emerging
- Collagen Peptides (oral)
- Hydroxyproline delivery, collagen substrate
- 10–15 g daily (human trials)
- 18% increase in gastric hydroxyproline
- Practical for oral administration; supports remodeling phase specifically
- KPV (Lys-Pro-Val tripeptide)
- α-MSH receptor activation, inflammation modulation
- 1–5 mg (topical/local, IBD models)
- Not quantified for ulcers; anti-inflammatory focus
- Promising for inflammatory component; ulcer-specific data limited